Mid-adulthood risk factor profiles for CKD

Journal of the American Society of Nephrology

Volumn 25, Issue 11, 2014, Pages 2633-2641

  McMahon, Gearoid M ^a   Preis, Sarah R ^c   Hwang, Shih Jen ^a   Fox, Caroline S ^a,b  

^a FRAMINGHAM HEART STUDY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; CREATININE;

ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; AGE DISTRIBUTION; ALBUMINURIA; DYSLIPIDEMIAS; GLOMERULUS FILTRATION RATE; HYPERTENSION, RENAL; OBESITY; PREDICTIVE VALUE; RENAL INSUFFICIENCY, CHRONIC; SENSITIVITY AND SPECIFICITY; URINE;

ADULT; AGE DISTRIBUTION; AGED; ALBUMINURIA; CREATININE; DYSLIPIDEMIAS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION, RENAL; MALE; OBESITY; PREDICTIVE VALUE OF TESTS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84924011828     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013070750     Document Type: Article

References (44)

1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G: Chronic kidney disease as a global public health problem: Approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72: 247-259, 2007
2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
3. Turin TC, Tonelli M, Manns BJ, Ravani P, Ahmed SB, Hemmelgarn BR: Chronic kidney disease and life expectancy. Nephrol Dial Transplant 27: 3182-3186, 2012
4. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 375: 2073-2081, 2010
5. Plantinga LC, Boulware LE, Coresh J, Stevens LA, Miller ER 3rd, Saran R, Messer KL, Levey AS, Powe NR: Patient awareness of chronic kidney disease: Trends and predictors. Arch Intern Med 168: 2268-2275, 2008
6. Hippisley-Cox J, Coupland C: Predicting the risk of chronic kidney disease in men and women in England and Wales: Prospective derivation and external validation of the QKidney Scores. BMC Fam Pract 11: 49, 2010
7. O' Seaghdha CM, Lyass A, Massaro JM, Meigs JB, Coresh J, D'Agostino RB Sr, Astor BC, Fox CS: A risk score for chronic kidney disease in the general population. Am J Med 125: 270-277, 2012
8. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA 291: 844-850, 2004
9. Taal MW, Brenner BM: Predicting initiation and progression of chronic kidney disease:Developing renal risk scores. Kidney Int 70: 1694-1705, 2006
10. Locatelli F, Vecchio LD, Pozzoni P: The importance of early detection of chronic kidney disease. Nephrol Dial Transplant 17[Suppl 11]: 2-7, 2002
11. Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY, Levine DM: Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med 328: 313-318, 1993
12. Loria CM, Liu K, Lewis CE, Hulley SB, Sidney S, Schreiner PJ, Williams OD, Bild DE, Detrano R: Early adult risk factor levels and subsequent coronary artery calcification: The CARDIA Study. J Am Coll Cardiol 49: 2013-2020, 2007
13. Wilkins JT, Ning H, Berry J, Zhao L, Dyer AR, Lloyd-Jones DM: Lifetime risk and years lived free of total cardiovascular disease. JAMA 308: 1795-1801, 2012
14. Othman M, Kawar B, El Nahas AM: Influence of obesity on progression of non-diabetic chronic kidney disease: A retrospective cohort study. Nephron Clin Pract 113: c16-c23, 2009
15. Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 59: 1498-1509, 2001
16. Goumenos DS, Kawar B, El Nahas M, Conti S, Wagner B, Spyropoulos C, Vlachojannis JG, Benigni A, Kalfarentzos F: Early histological changes in the kidney of people with morbid obesity. Nephrol Dial Transplant 24: 3732-3738, 2009
17. Shen WW, Chen HM, Chen H, Xu F, Li LS, Liu ZH: Obesity-related glomerulopathy: Body mass index and proteinuria. Clin J Am Soc Nephrol 5: 1401-1409, 2010
18. Navaneethan SD, Yehnert H, Moustarah F, Schreiber MJ, Schauer PR, Beddhu S: Weight loss interventions in chronic kidney disease: A systematic review and meta-analysis. Clin J Am Soc Nephrol 4: 1565-1574, 2009
19. Silverwood RJ, Pierce M, Thomas C, Hardy R, Ferro C, Sattar N, Whincup P, Savage C, Kuh D, Nitsch D; National Survey of Health and Development Scientific and Data Collection Teams: Association between younger age when first overweight and increased risk for CKD. J Am Soc Nephrol 24: 813-821, 2013
20. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ: Prevalence of high blood pressure and elevated serum creatinine level in the United States: Findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 161: 1207-1216, 2001
21. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C: Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med 165: 923-928, 2005
22. Egan BM, Zhao Y, Axon RN: US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 303: 2043-2050, 2010
23. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboli P, Conte G, Gabbai FB, De Nicola L: Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med 171: 1090-1098, 2011
24. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB: General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 117: 743-753, 2008
25. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD: Metabolic syndrome and kidney disease: A systematic review and meta-analysis. Clin J Am Soc Nephrol 6: 2364-2373, 2011
26. Lee HS: Mechanisms and consequences of hypertriglyceridemia and cellular lipid accumulation in chronic kidney disease and metabolic syndrome. Histol Histopathol 26: 1599-1610, 2011
27. Vaziri ND, Norris K: Lipid disorders and their relevance to outcomes in chronic kidney disease. Blood Purif 31: 189-196, 2011
28. Vasan RS, D'Agostino RB Sr: Age and time need not and should not be eliminated from the coronary risk prediction models. Circulation 111: 542-545, 2005
29. Nikpour M, Urowitz MB, Ibanez D, Harvey PJ, Gladman DD: Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: A prospective proof-of-concept cohort study. Arthritis Res Ther 13: R156, 2011
30. Kuh D, Ben-Shlomo Y, Lynch J, Hallqvist J, Power C: Life course epidemiology. J Epidemiol Community Health 57: 778-783, 2003
31. National Kidney Foundation: KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease: Management of progression and complications of CKD. Kidney Int Suppl 3: 73-90, 2013
32. Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F; ACCORD Study Group: Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 362: 1575-1585, 2010
33. Upadhyay A, Earley A, Haynes SM, Uhlig K: Systematic review: Blood pressure target in chronic kidney disease and proteinuria as an effect modifier. Ann Intern Med 154: 541-548, 2011
34. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F; ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl JMed 358: 2560-2572, 2008
35. Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT; Action to Control Cardiovascular Risk in Diabetes Study Group: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358: 2545-2559, 2008
36. Kalaitzidis RG, Elisaf MS: The role of statins in chronic kidney disease. Am J Nephrol 34: 195-202, 2011
37. Karmali KN, Lloyd-Jones DM: Adding a life-course perspective to cardiovascular-risk communication. Nat Rev Cardiol 10: 111-115, 2013
38. Preis SR, Pencina MJ, Mann DM, D'Agostino RB Sr, Savage PJ, Fox CS: Early-adulthood cardiovascular disease risk factor profiles among individuals with and without diabetes in the Framingham Heart Study. Diabetes Care 36: 1590-1596, 2013
39. Liu K, Daviglus ML, Loria CM, Colangelo LA, Spring B, Moller AC, Lloyd-Jones DM: Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age: The Coronary Artery Risk Development in (Young) Adults (CARDIA) study. Circulation 125: 996-1004, 2012
40. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PW, Wolf PA, Levy D: Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation 113: 791-798, 2006
41. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP: An investigation of coronary heart disease in families. The Framingham Offspring Study. Am J Epidemiol 110: 281-290, 1979
42. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
43. Wacholder S, Silverman DT, McLaughlin JK, Mandel JS: Selection of controls in case-control studies. III. Design options. Am J Epidemiol 135: 1042-1050, 1992
44. Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS: Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39: 920-929, 2002